250 / 264
Selected Section Materials by Author
I - 5
Carnaby-Mann G, Crary MA, Schmalfuss I, Amdur R. “Pharyngocise”: randomized controlled trial of
preventative exercises to maintain muscle structure and swallowing function during head-and-neck
chemoradiotherapy.
Int J Radiat Oncol Biol Phys
. 2012; 83(1): 209-216. EBM level 1
Cheung PK, Chin RY, Eslick GD. Detecting residual/recurrent head neck squamous cell carcinomas using PET
or PET/CT: systematic review and meta-analysis.
Otolaryngol Head Neck Surg
. 2016;154(3):421-432. EBM
level 2
Choby GW, Kim J, Ling DC, et al. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life
outcomes.
JAMA Otolaryngol Head Neck Surg
. 2015; 141(6):499-504. EBM level 4
Durham AB, Lowe L, Malloy KM, et al. Sentinel lymph node biopsy for cutaneous squamous cell carcinoma
on the head and neck.
JAMA Otolaryngol Head Neck Surg
. 2016; 142(12):1171-1176. EBM level 4
Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese
patients.
World J Surg
. 2010; 34(1):28-35. EBM level 2
Kumar B, Cipolla MJ, Old MO, et al. Surgical management of oropharyngeal squamous cell carcinoma:
survival and functional outcomes.
Head Neck
. 2016; 38 Suppl 1:E1794-1802. EBM level 3
Lang BH, Ng SH, Lau LL, et al. A systematic review and meta-analysis of prophylactic central neck dissection
on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy.
Thyroid
. 2013;
23(9):1087-1098. EBM level 1
Lang BH, Wong IO, Wong KP, et al. Risk of second primary malignancy in differentiated thyroid carcinoma
treated with radioactive iodine therapy.
Surgery
. 2012; 151(6):844-850. EBM level 2
Mazzaglia PJ. Surgeon-performed ultrasound in patients referred for thyroid disease improves patient care by
minimizing performance of unnecessary procedures and optimizing surgical treatment.
World J Surg
. 2010;
34(6):1164-1170. EBM level 3
Mehta V, Nathan CA. What is the role of sentinel lymph node biopsy in early-stage oral cavity carcinoma?
Laryngoscope
. 2016; 126(1):9-10. EBM level 4
Morris LG, Sikora AG, Tosteson TD, Davies L. The increasing incidence of thyroid cancer: the influence of
access to care.
Thyroid
. 2013; 23(7):885-891. EBM level 1
Oltmann SC, Schneider DF, Chen H, Sippel RS. All thyroid ultrasound evaluations are not equal: sonographers
specialized in thyroid cancer correctly label clinical N0 disease in well differentiated thyroid cancer.
Ann Surg
Oncol
. 2015; 22(2):422-428. EBM level 3
Papagerakis S, Bellile E, Peterson LA, et al. Proton pump inhibitors and histamine 2 blockers are associated
with improved overall survival in patients with head and neck squamous carcinoma.
Cancer Prev Res (Phila)
.
2014; 7(12):1258-1269. EBM level 3
Peng KA, Kuan EC, Unger L, et al. A swallow preservation protocol improves function for veterans receiving
chemoradiation for head and neck cancer.
Otolaryngol Head Neck Surg
. 2015; 152(5): 863-867. EBM level 3
Reeve BB, Cai J, Zhang H, et al. Factors that impact health-related quality of life over time for individuals with
head and neck cancer.
Laryngoscope
. 2016; 126(12):2718-2725. EBM level 4